feed,title,long_url,short_url
Benzinga,"Roche, Exelixis Report Second Flop Out Of Three Trials Evaluating Cabozantinib/Atezolizumab Combo",https://benzinga.com/general/biotech/23/03/31193407/roche-exelixis-report-second-flop-out-of-three-trials-evaluating-cabozantinibatezolizumab-combo,https://da.gd/SgMPr
